Neonatal Bacillus Calmette-Guérin Vaccination Decreases Eczema Incidence at 5 years : The MIS BAIR Randomised Controlled Trial
ContributorsPittet, Laure
; Messina, Nicole L
; Francis, Kate L
; Donath, Susan; Flanagan, Katie L; Forbes, Emily K; Gardiner, Kaya
; Phillips, Roderic J; Ponsonby, Anne-Louise
; Robins-Browne, Roy; Shann, Frank; South, Mike
; Vuillermin, Peter
; Casalaz, Dan; Curtis, Nigel
; Melbourne Infant Study : BCG for Allergy and Infection Reduction (MIS BAIR) Group
Published inAllergy, vol. 80, no. 12, p. 3444-3446
Publication date2025-12
First online date2025-07-31
Keywords
- Atopic dermatitis
- Prevention
- Vaccines
Affiliation entities
Funding
- National Health and Medical Research Council [GNT1051228]
- National Health and Medical Research Council [GNT1099676]
- National Health and Medical Research Council [GNT1197117]
- Swiss National Science Foundation - Exploring the heterologous effect of vaccination [178155]
- Swiss National Science Foundation - Harnessing the beneficial non-specific effects of early measles vaccination in children [209050]
Citation (ISO format)
PITTET, Laure et al. Neonatal Bacillus Calmette-Guérin Vaccination Decreases Eczema Incidence at 5 years : The MIS BAIR Randomised Controlled Trial. In: Allergy, 2025, vol. 80, n° 12, p. 3444–3446. doi: 10.1111/all.16677
Main files (1)
Article (Published version)
Secondary files (1)
Appendix
Identifiers
- PID : unige:193210
- DOI : 10.1111/all.16677
- PMID : 40742161
- PMCID : PMC12666751
Journal ISSN0105-4538
